Reimagine Care is a technology company.
Reimagine Care has raised $25.0M across 1 funding round.
Reimagine Care has raised $25.0M in total across 1 funding round.
Reimagine Care is a healthcare technology company founded in 2020 that builds a virtual oncology care platform delivering on-demand, at-home cancer treatment support.[1][2] It serves healthcare systems, independent oncology practices, and risk-bearing entities by solving key challenges in cancer care, such as proactive symptom management, medication adherence, and reducing avoidable emergency visits through AI-powered tools and 24/7 clinical access.[1][2][3] The platform integrates an AI virtual assistant named Remi, evidence-based care pathways, digital monitoring, ePRO surveys, and oncology experts, enabling high-quality, patient-centered care that works in both fee-for-service and value-based models while improving outcomes and provider efficiency.[2][3][4]
This approach addresses the supply-demand gap in oncology by extending clinic care beyond walls, with reported results like resolving 90% of symptoms without escalation to primary teams.[3]
Reimagine Care was founded in 2020 and is headquartered in Nashville, Tennessee, emerging amid the acceleration of virtual care during the COVID-19 pandemic.[1][2] While specific founder details are not detailed in available sources, the company was established by leaders focused on transforming the cancer treatment experience, driven by the belief that patients deserve better well-being, connectivity to care teams, and time for what they love.[2][4] CEO Dan Nardi has highlighted the company's roots in partnering with providers to support patients beyond clinic walls, leveraging AI and clinical expertise for proactive care.[3]
Early traction built on integrating technologies like AI assistants and remote monitoring, positioning it as an extension of oncology practices rather than a replacement, with rapid adoption by health systems seeking to manage higher patient volumes efficiently.[3]
Reimagine Care rides the wave of digital health transformation in oncology, fueled by post-pandemic demand for at-home care, AI-driven personalization, and value-based reimbursement shifts.[3][4] Timing aligns with oncology workforce shortages and rising oral oncolytic use, enabling safe clinic-to-home transitions amid a supply-demand imbalance.[1][3] Market forces like EHR interoperability mandates, RPM adoption, and payer incentives for reduced hospitalizations favor its model, which extends provider reach without resource strain.[2][4]
It influences the ecosystem by pioneering collaborative virtual care as a "nervous system" for oncology practices, setting standards for AI-clinical hybrids that could expand to other chronic conditions.[3]
Reimagine Care is poised to scale as an indispensable oncology extension, with expansion into broader chronic care via its RC Assistant platform and AI enhancements.[3][4] Trends like AI triage ubiquity, virtual nursing mandates, and homecentered value-based contracts will propel growth, potentially capturing more market share in a $200B+ U.S. oncology spend.[1] Its influence may evolve from niche partner to ecosystem leader, redefining accessible cancer care—echoing its founding vision of prioritizing patient joy through tech-enabled humanity.[2]
Reimagine Care has raised $25.0M in total across 1 funding round.
Reimagine Care's investors include Alpha Venture Partners, Santé Ventures.
Reimagine Care has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $25.0M Series A | Alpha Venture Partners, Santé Ventures |